Search by Drug Name or NDC

    NDC 00006-5331-59 WELIREG 40 mg/1 Details

    WELIREG 40 mg/1

    WELIREG is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is BELZUTIFAN.

    Product Information

    NDC 00006-5331
    Product ID 0006-5331_609c65d7-4bcd-4d2d-bad5-63a38cdd1b16
    Associated GPIs 21421020000320
    GCN Sequence Number 082589
    GCN Sequence Number Description belzutifan TABLET 40 MG ORAL
    HIC3 V16
    HIC3 Description ANTINEOPLASTIC-HYPOXIA INDUCIBLE FACTOR (HIF) INH
    GCN 50046
    HICL Sequence Number 047546
    HICL Sequence Number Description BELZUTIFAN
    Brand/Generic Brand
    Proprietary Name WELIREG
    Proprietary Name Suffix n/a
    Non-Proprietary Name belzutifan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name BELZUTIFAN
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Cytochrome P450 3A4 Inducers [MoA], Hypoxia-inducible Factor 2 alpha Inhibitors [MoA], Hypoxia-inducible Factor Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215383
    Listing Certified Through 2025-12-31

    Package

    NDC 00006-5331-59 (00006533159)

    NDC Package Code 0006-5331-59
    Billing NDC 00006533159
    Package 1 BOTTLE in 1 CARTON (0006-5331-59) / 90 TABLET, FILM COATED in 1 BOTTLE
    Marketing Start Date 2023-06-21
    NDC Exclude Flag N
    Pricing Information N/A